Otros idiomas Zhejiang CONBA Pharmaceutical Co.,Ltd.

Acciones

600572

CNE000001H86

Precio de cierre Shanghai S.E. Otros sitios de cotización 00:00:00 03/07/2024			Varia. Cinco días.	Varia. 1 de enero.
4,47 ^CNY	-1,32 %		-3,04 %	-11,49 %

27/06	CONBA Pharmaceutical obtiene el visto bueno para comercializar comprimidos de tadalafilo; las acciones caen un 3%	MT
26/04	Zhejiang CONBA Pharmaceutical Co.,Ltd. Resultados del primer trimestre finalizado el 31 de marzo de 2024	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

CONBA Pharma's Unit Gets Nod to Market Antidepressant Drug; Shares Down 3%	27/06
CONBA Pharmaceutical Gets Nod to Market Tadalafil Tablets; Shares Down 3%	27/06
Zhejiang CONBA Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04
Zhejiang CONBA Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	19/04
Tranche Update on Zhejiang CONBA Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on January 23, 2024.	01/04
Shanghai-Listed Firms Actively Repurchase Shares as Regulators Focus on Market Value	02/02
Shanghai Dingjia Trading Co., Ltd. agreed to acquire 20% stake in Shanghai Kede Network Technology Co., Ltd. from Zhejiang CONBA Pharmaceutical Co.,Ltd. for CNY 26 million.	01/02
Zhejiang CONBA Pharmaceutical Co.,Ltd. announces an Equity Buyback for CNY 400 million worth of its shares.	23/01
Zhejiang CONBA Pharmaceutical Co.,Ltd. authorizes a Buyback Plan.	22/01
CONBA Pharma Gets Nod to Trial Cough Medicine	28/11
CONBA Pharma Unit's Acetyl Cysteine Granules Chosen for China's Centralized Drug Procurement	08/11
Zhejiang CONBA Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	27/10/23
Zhejiang CONBA Pharmaceutical Co.,Ltd.(XSSC:600572) added to S&P Global BMI Index	18/09/23
Zhejiang CONBA Pharmaceutical Co.,Ltd.(XSSC:600572) added to FTSE All-World Index	18/09/23
Zhejiang CONBA Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	04/08/23
Wuxi China Life Chengda Equity Investment Center (Limited Partnership) and Jinhua Future Yicai Phase I Equity Investment Partnership (Limited Partnership) completed the acquisition of 7.84% stake in Jiangxi Zhenshiming Pharmaceutical Co., Ltd. from Zhejiang CONBA Pharmaceutical Co.,Ltd.	07/07/23
CONBA Pharma Gets Drug Registration for Risperidone Oral Solution	25/05/23
Wuxi China Life Chengda Equity Investment Center (Limited Partnership) and Jinhua Future Yicai Phase I Equity Investment Partnership (Limited Partnership) intends to acquire 7.84% stake in Jiangxi Zhenshiming Pharmaceutical Co., Ltd. from Zhejiang CONBA Pharmaceutical Co.,Ltd for CNY 290 million.	29/04/23
Zhejiang CONBA Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	18/04/23
Zhejiang CONBA Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	14/04/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Zhejiang CONBA Pharmaceutical Co.,Ltd.

Acciones

600572

CNE000001H86

Otros idiomas

Filtros